689 related articles for article (PubMed ID: 12163021)
21. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells.
Kojima H; Toda M; Sitkovsky MV
Int Immunol; 2000 Mar; 12(3):365-74. PubMed ID: 10700471
[TBL] [Abstract][Full Text] [Related]
22. Early pregnancy decidual lymphocytes beside perforin use Fas ligand (FasL) mediated cytotoxicity.
Crncic TB; Laskarin G; Frankovic KJ; Tokmadzic VS; Strbo N; Bedenicki I; Le Bouteiller P; Tabiasco J; Rukavina D
J Reprod Immunol; 2007 Apr; 73(2):108-117. PubMed ID: 16950518
[TBL] [Abstract][Full Text] [Related]
23. RKTS-33, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Hayashi Y; Osada H; Kataoka T
Biosci Biotechnol Biochem; 2005 Oct; 69(10):1923-8. PubMed ID: 16244443
[TBL] [Abstract][Full Text] [Related]
24. Caspase dependence of target cell damage induced by cytotoxic lymphocytes.
Sarin A; Haddad EK; Henkart PA
J Immunol; 1998 Sep; 161(6):2810-6. PubMed ID: 9743340
[TBL] [Abstract][Full Text] [Related]
25. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
27. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
Aung S; Graham BS
J Immunol; 2000 Apr; 164(7):3487-93. PubMed ID: 10725701
[TBL] [Abstract][Full Text] [Related]
28. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
29. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
[TBL] [Abstract][Full Text] [Related]
30. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage.
Ohshima K; Suzumiya J; Shimazaki K; Kato A; Tanaka T; Kanda M; Kikuchi M
Histopathology; 1997 Nov; 31(5):444-50. PubMed ID: 9416485
[TBL] [Abstract][Full Text] [Related]
31. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
Melgar S; Bas A; Hammarström S; Hammarström ML
Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
[TBL] [Abstract][Full Text] [Related]
32. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
33. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
34. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
36. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
37. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
38. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
[TBL] [Abstract][Full Text] [Related]
39. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
